Management of women with menorrhagia in primary and secondary care (n=885)
| Investigation/drug/referral/operation |
% all women (range for 11 practices) |
| Vaginal examination | 41.8 (28.8 to 68.2) |
| Full blood count | 39.3 (32.4 to 45.3) |
| Pelvic ultrasound scan | 12.5 (3.8 to 25.4) |
| Tranexamic acid | 14.7 (6.3 to 56.3) |
| Mefenamic acid | 26.6 (10.9 to 42.2) |
| Tranexamic and/or mefenamic acid | 37.2 (15.6 to 71.9) |
| Norethisterone | 37.2 (20.3 to 57.8)1-150 |
| Levonorgestrel releasing intrauterine device | 2.1 (0.0 to 6.3) |
| Gynaecology referral | 37.6 (24.4 to 51.6) |
| Endometrial sampling (by pipelle or hysteroscopy) | 16.4 (7.7 to 7.5) |
| Dilatation and curettage (D&C) | 5.4 (1.3 to 12.8) |
| Transcervical resection of endometrium (TCRE) | 2.5 (1.3 to 3.4) |
| Hysterectomy | 15.5 (7.8 to 22.7) |
↵1-150 Data missing for one practice.